Vanguard Group Inc Astria Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,635,520 shares of ATXS stock, worth $24.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,635,520

Previous 2,590,160 1.75%

Holding current value

$24.5 Million

Previous $23.6 Million 23.11%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$8.97 - $12.65 $406,879 - $573,804	45,360 Added 1.75%	2,635,520 $29 Million
Q2 2024 Aug 13, 2024	BUY	$8.83 - $13.51 $479,195 - $733,174	54,269 Added 2.14%	2,590,160 $23.6 Million
Q1 2024 May 10, 2024	BUY	$6.99 - $16.69 $3.36 Million - $8.01 Million	480,184 Added 23.36%	2,535,891 $35.7 Million
Q4 2023 Feb 14, 2024	BUY	$4.42 - $8.06 $2.41 Million - $4.4 Million	545,786 Added 36.15%	2,055,707 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$6.89 - $9.86 $20,015 - $28,643	2,905 Added 0.19%	1,509,921 $11.3 Million
Q2 2023 Aug 14, 2023	BUY	$8.33 - $13.72 $1.58 Million - $2.61 Million	190,163 Added 14.44%	1,507,016 $12.6 Million
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $7.42 Million - $10.5 Million	662,527 Added 101.25%	1,316,853 $17.5 Million
Q4 2022 Feb 10, 2023	BUY	$7.44 - $14.89 $916,407 - $1.83 Million	123,173 Added 23.19%	654,326 $9.74 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $10.34 $82,396 - $286,862	27,743 Added 5.51%	531,153 $4.8 Million
Q2 2022 Aug 12, 2022	SELL	$2.46 - $6.96 $71,728 - $202,939	-29,158 Reduced 5.47%	503,410 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$5.08 - $8.62 $108,356 - $183,864	-21,330 Reduced 3.85%	532,568 $2.87 Million
Q3 2021 Nov 12, 2021	BUY	$7.32 - $12.9 $4.05 Million - $7.15 Million	553,898 New	553,898 $4.9 Million

Others Institutions Holding ATXS

# of Institutions

107

Shares Held

48.6M

Call Options Held

48K

Put Options Held

9.3K

View Full List

About Astria Therapeutics, Inc.

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $141M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

More about ATXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Astria Therapeutics, Inc. Transaction History